Cambiar Investors LLC Has $8.70 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)

Cambiar Investors LLC boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,087 shares of the medical research company’s stock after buying an additional 8,607 […]

Related Keywords

Canada ,United States ,Josephw Laplume ,Asia Pacific ,Research Models ,Clearbridge Investments ,Credit Suisse Group ,Quarter For Charles River Laboratories International ,Moneta Group Investment Advisors ,Cambiar Investors ,Charles River Laboratories International Stock Down ,Charles River Laboratories International Inc ,Charles River Laboratories International Company Profile ,Charles River Laboratories International ,Wells Fargo Company ,Vanguard Group Inc ,Exchange Commission ,Citigroup ,Securities Exchange Commission ,Manufacturing Solutions ,Pricet Rowe Associates Inc ,Free Report ,Street Corp ,Group Investment Advisors ,Charles River Laboratories ,Suisse Group ,Wells Fargo ,River Laboratories International Stock Down ,River Laboratories International ,Get Free Report ,Safety Assessment ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,